Abstract PS4-39: Efficacy of combined CDK4/6 inhibitor and PARP inhibitor in the treatment of BRCA1 mutant triple negative breast cancer
Authors: Xiuzhi Zhu, Li Chen, Zhonghua Wang
Published: 2021-02-15
DOI:
10.1158/1538-7445.sabcs20-ps4-39
Source:
Full article
Abstract
Abstract